ERCC2 and central nervous system cancer: [55] showed that of 7 polymorphic sites in the XPD  gene, maximum association with an increased risk of glioma was observed for the least studied synonymous Arg156Arg polymorphism, which may be a marker of another unknown gene that predisposes potential patients to this disease.